Search research articles
Contact Us
Filters
Showing results (111-120 of 125) with videos related to
Page
of 13
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 4, 2000
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints
D R Ferry, M Deakin, J Baddeley, et al.
Thorax
|
September 13, 2008
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer
S M Lee, L E James, W Qian, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 23, 1999
Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine
P J Julyan, L W Seymour, D R Ferry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 28, 2017
A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification
E Van Cutsem, Y-J Bang, W Mansoor, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2013
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial
Josep Tabernero, Eric Van Cutsem, Radek Lakomý, et al.
Cancer Chemotherapy and Pharmacology
|
May 4, 2018
Exposure-response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer
Egbert F Smit, Edward B Garon, Martin Reck, et al.
The New England Journal of Medicine
|
June 19, 1998
Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators
W E Boden, R A O'Rourke, M H Crawford, et al.
Lancet (London, England)
|
July 17, 2007
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
Matthew T Seymour, Timothy S Maughan, Jonathan A Ledermann, et al.
International Journal of Oncology
|
May 9, 2009
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer
Leonard W Seymour, David R Ferry, David J Kerr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2014
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy
Paul Ruff, David R Ferry, Radek Lakomỳ, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 125) with videos related to
Sort By:
Page
of 13
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 4, 2000
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints
D R Ferry, M Deakin, J Baddeley, et al.
Thorax
|
September 13, 2008
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer
S M Lee, L E James, W Qian, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 23, 1999
Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine
P J Julyan, L W Seymour, D R Ferry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 28, 2017
A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification
E Van Cutsem, Y-J Bang, W Mansoor, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2013
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial
Josep Tabernero, Eric Van Cutsem, Radek Lakomý, et al.
Cancer Chemotherapy and Pharmacology
|
May 4, 2018
Exposure-response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer
Egbert F Smit, Edward B Garon, Martin Reck, et al.
The New England Journal of Medicine
|
June 19, 1998
Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators
W E Boden, R A O'Rourke, M H Crawford, et al.
Lancet (London, England)
|
July 17, 2007
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
Matthew T Seymour, Timothy S Maughan, Jonathan A Ledermann, et al.
International Journal of Oncology
|
May 9, 2009
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer
Leonard W Seymour, David R Ferry, David J Kerr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2014
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy
Paul Ruff, David R Ferry, Radek Lakomỳ, et al.
Page
of 13